The role of adiponectin in gastric cancer

Abstract

Adiponectin, an adipokine synthesized by adipose tissue, has garnered significant attention in biomedical investigations. Research on its implications suggests that reduced adiponectin levels in the bloodstream might serve as a potential predisposing factor for several types of cancers, including gastric cancer. Although many studies on adiponectin levels in gastric cancer patients have been reported, its predictive role as a biomarker remains controversial. Moreover, the significance of adiponectin receptor expression as a prognostic factor in gastric cancer tissues varies across different research studies, and the precise mechanism by which adiponectin influences the initiation and advancement of gastric cancer remains to be fully elucidated. Furthermore, the anti-inflammatory and postoperative anti-infective effects of adiponectin are worth further investigation. Based on existing studies, it is commonly suggested that in the presence of low adiponectin levels, the stomach might be vulnerable to stimulation or damage from certain carcinogens, promoting gastric cancer development and progression. Considering its complex systemic effects and high serum concentration, adiponectin might serve as a homeostasis regulator and not necessarily as an anti-cancer factor. In this review, we explore the current research available on adiponectin in relation to gastric cancer and discuss its role and corresponding receptors involved in gastric cancer.

Keywords

Adiponectin / adiponectin receptor / gastric cancer

References

[1] Sung H,Siegel RL.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2021;71:209-49

[2] Avgerinos KI,Mantzoros CS.Obesity and cancer risk: emerging biological mechanisms and perspectives.Metabolism2019;92:121-35

[3] Dermitzaki E,Spyridaki EC.Adiponectin levels may help assess the clinical repercussions of obesity irrespective of body mass index.Hormones2017;16:271-81

[4] Mohammadi M.Role of obesity in the tumorigenesis of gastric cancer.Int J Prev Med2020;11:148 PMCID:PMC7643578

[5] Szablewski L.Introductory chapter: types of adipose tissue. In: Szablewski L, editor. Adipose tissue. London: InTech; 2018.

[6] Otani K,Yamaguchi H.Adiponectin and colorectal cancer.Surg Today2017;47:151-8

[7] Miyoshi Y,Kihara S.Association of serum adiponectin levels with breast cancer risk.Clin Cancer Res2003;9:5699-704

[8] Chen X.Adiponectin and breast cancer.Med Oncol2011;28:1288-95

[9] Słabuszewska-Jóźwiak A,Janicka-Kośnik M,Jakiel G.Role of leptin and adiponectin in endometrial cancer.Int J Mol Sci2022;23:5307 PMCID:PMC9141615

[10] Hu X,Zhang C,Long S.Role of adiponectin in prostate cancer.Int Braz J Urol2019;45:220-8 PMCID:PMC6541146

[11] Khoramipour K,Hekmatikar AA.Adiponectin: structure, physiological functions, role in diseases, and effects of nutrition.Nutrients2021;13:1180 PMCID:PMC8066826

[12] Scherer PE,Fogliano M,Lodish HF.A novel serum protein similar to C1q, produced exclusively in adipocytes.J Biol Chem1995;270:26746-9

[13] Goldfine AB.Adiponectin: linking the fat cell to insulin sensitivity.Lancet2003;362:1431-2

[14] Yadav A,Saini V.Role of leptin and adiponectin in insulin resistance.Clin Chim Acta2013;417:80-4

[15] Vona-Davis L,Rose DP.Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer.Obes Rev2007;8:395-408

[16] Pajvani UB,Combs TP.Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity.J Biol Chem2003;278:9073-85

[17] Hu E,Spiegelman BM.AdipoQ is a novel adipose-specific gene dysregulated in obesity.J Biol Chem1996;271:10697-703

[18] Arita Y,Ouchi N.Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.Biochem Biophys Res Commun1999;257:79-83

[19] Brochu-Gaudreau K,Blouin R,Murphy BD.Adiponectin action from head to toe.Endocrine2010;37:11-32

[20] Yamauchi T,Ito Y.Cloning of adiponectin receptors that mediate antidiabetic metabolic effects.Nature2003;423:762-9

[21] Holland WL,Wang ZV.Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin.Nat Med2011;17:55-63

[22] Miyazaki T,Uzuki M.Adiponectin activates c-Jun NH2-terminal kinase and inhibits signal transducer and activator of transcription 3.Biochem Biophys Res Commun2005;333:79-87

[23] Yamauchi T,Maki T.Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions.Nat Med2007;13:332-9

[24] Hug C,Ahmad NS,Tsao TS.T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin.Proc Natl Acad Sci USA2004;101:10308-13 PMCID:PMC478568

[25] Bråkenhielm E,Cao R.Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis.Proc Natl Acad Sci USA2004;101:2476-81 PMCID:PMC356975

[26] Zhou L,Etzler JC.Adiponectin activates AMP-activated protein kinase in muscle cells via APPL1/LKB1-dependent and phospholipase C/Ca²⁺/Ca²⁺/calmodulin-dependent protein kinase kinase-dependent pathways.J Biol Chem2009;284:22426-35 PMCID:PMC2755964

[27] Zuo Y,Qiu X,Zhang S.Adiponectin reduces apoptosis of diabetic cardiomyocytes by regulating miR-711/TLR4 axis.Diabetol Metab Syndr2022;14:131 PMCID:PMC9479314

[28] Deepa SS.APPL1: role in adiponectin signaling and beyond.Am J Physiol Endocrinol Metab2009;296:E22-36 PMCID:PMC2636986

[29] Shrestha A,Kim MJ.Critical role of AMPK/FoxO3A axis in globular adiponectin-induced cell cycle arrest and apoptosis in cancer cells.J Cell Physiol2016;231:357-69

[30] Koerner A,Kiess W.Adipocytokines: leptin-the classical, resistin-the controversical, adiponectin-the promising, and more to come.Best Pract Res Clin Endocrinol Metab2005;19:525-46

[31] Maeda N,Kishida K.Diet-induced insulin resistance in mice lacking adiponectin/ACRP30.Nat Med2002;8:731-7

[32] Bruun JM,Verdich C.Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans.Am J Physiol Endocrinol Metab2003;285:E527-33

[33] Tilg H.Adipocytokines: mediators linking adipose tissue, inflammation and immunity.Nat Rev Immunol2006;6:772-83

[34] Ogunwobi OO.Adiponectin stimulates proliferation and cytokine secretion in colonic epithelial cells.Regul Pept2006;134:105-13

[35] Ye JJ,Lim J.Adiponectin and related C1q/TNF-related proteins bind selectively to anionic phospholipids and sphingolipids.Proc Natl Acad Sci USA2020;117:17381-8 PMCID:PMC7382265

[36] Masaki T,Tatsukawa H.Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ay obese mice.Hepatology2004;40:177-84

[37] Lira FS,Pimentel GD.Both adiponectin and interleukin-10 inhibit LPS-induced activation of the NF-κB pathway in 3T3-L1 adipocytes.Cytokine2012;57:98-106

[38] Liu LJ,Zhu J,Zhao XZ.Adiponectin alleviates liver injury in sepsis rats through AMPK/MTOR pathway.Eur Rev Med Pharmacol Sci2020;24:10745-52

[39] Kato H,Shiraga M.Adiponectin acts as an endogenous antithrombotic factor.Arterioscler Thromb Vasc Biol2006;26:224-30

[40] Matsuo Y,Kuroi A.Effects of plasma adiponectin levels on the number and function of endothelial progenitor cells in patients with coronary artery disease.Circ J2007;71:1376-82

[41] Ouedraogo R,Xu SQ.Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway.Diabetes2006;55:1840-6

[42] Fenton JI.Adipokine regulation of colon cancer: adiponectin attenuates interleukin-6-induced colon carcinoma cell proliferation via STAT-3.Mol Carcinog2010;49:700-9 PMCID:PMC2908512

[43] Nigro E,Polito R.Adiponectin and colon cancer: evidence for inhibitory effects on viability and migration of human colorectal cell lines.Mol Cell Biochem2018;448:125-35

[44] Mantzoros C,Dessypris N.Adiponectin and breast cancer risk.J Clin Endocrinol Metab2004;89:1102-7

[45] Dal Maso L,Karalis A.Circulating adiponectin and endometrial cancer risk.J Clin Endocrinol Metab2004;89:1160-3

[46] Ishikawa M,Kazama S,Hatano K.Plasma adiponectin and gastric cancer.Clin Cancer Res2005;11:466-72

[47] Goktas S,Caglar K,Kilic S.Prostate cancer and adiponectin.Urology2005;65:1168-72

[48] Chang MC,Su TC.Adiponectin as a potential differential marker to distinguish pancreatic cancer and chronic pancreatitis.Pancreas2007;35:16-21

[49] Arano T,Tateishi R.Serum level of adiponectin and the risk of liver cancer development in chronic hepatitis C patients.Int J Cancer2011;129:2226-35

[50] Seker M,Sonmez B.The association of serum adiponectin levels with histopathological variables in gastric cancer patients.Med Oncol2010;27:1319-23

[51] Ishikawa M,Yamauchi T.Adiponectin inhibits the growth and peritoneal metastasis of gastric cancer through its specific membrane receptors AdipoR1 and AdipoR2.Cancer Sci2007;98:1120-7

[52] Hamabe-Horiike T,Yoshida K,Yamaguchi T.Adipocytes contribute to tumor progression and invasion of peritoneal metastasis by interacting with gastric cancer cells as cancer associated fibroblasts.Cancer Rep2023;6:e1647 PMCID:PMC9875653

[53] Iwata Y,Saigo C,Takeuchi T.Anti-fibrotic properties of an adiponectin paralog protein, C1q/TNF-related protein 6 (CTRP6), in diffuse gastric adenocarcinoma.J Cancer2021;12:1161-8 PMCID:PMC7797637

[54] Barresi V,Giuffrè G,Barresi G.The expression of adiponectin receptors Adipo-R1 and Adipo-R2 is associated with an intestinal histotype and longer survival in gastric carcinoma.J Clin Pathol2009;62:705-9

[55] Zatorski H,Zielińska M.AdipoRon, an orally active, synthetic agonist of AdipoR1 and AdipoR2 receptors has gastroprotective effect in experimentally induced gastric ulcers in mice.Molecules2021;26:2946 PMCID:PMC8156685

[56] Yamamoto H,Uji Y.Association between reduction of plasma adiponectin levels and risk of bacterial infection after gastric cancer surgery.PLoS One2013;8:e56129 PMCID:PMC3592855

[57] Kordafshari M,Mehrvar N.Expression of AdipoR1 and AdipoR2 and serum level of adiponectin in gastric cancer.Gastrointest Tumors2020;7:103-9 PMCID:PMC7590762

[58] Nakajima TE,Hamano T.Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer.J Gastroenterol2009;44:685-90

[59] Jiang H,Wang J,He C.Adiponectin and the risk of gastrointestinal cancers in East Asians: Mendelian randomization analysis.Cancer Med2022;11:2397-404 PMCID:PMC9189470

[60] Otani K,Kamei T.Adiponectin receptors are downregulated in human gastric cancer.J Gastroenterol2010;45:918-27

[61] Lin YC,Yeh TS.Visceral-to-subcutaneous fat ratio independently predicts the prognosis of locally advanced gastric cancer - highlighting the role of adiponectin receptors and PPARα, β/δ, ɤ.Eur J Surg Oncol2021;47:3064-73

[62] Ayyildiz T,Ugras N.The expression and relationship of AdipoR1/R2 in gastric intestinal metaplasia.Niger J Clin Pract2021;24:608-13

[63] Shin E,Kim HH,Choe G.Adiponectin receptor expression in gastric carcinoma: implications in tumor development and progression.J Cancer Res Clin Oncol2013;139:709-18

[64] Tsukada T,Harada S.Adiponectin receptor-1 expression is associated with good prognosis in gastric cancer.J Exp Clin Cancer Res2011;30:107 PMCID:PMC3223499

[65] Ayyildiz T,Ugras N,Adim SB.Lack of any prognostic relationship between adiponectin receptor (Adipo R1/R2) expression for early/advanced stage gastric cancer.Asian Pac J Cancer Prev2014;15:4711-6

[66] Ramzan AA,Hicks D.Adiponectin receptor agonist AdipoRon induces apoptotic cell death and suppresses proliferation in human ovarian cancer cells.Mol Cell Biochem2019;461:37-46 PMCID:PMC7490954

[67] Ragone A,Spina A,Sapio L.Integrating gemcitabine-based therapy with adiporon enhances growth inhibition in human PDAC cell lines.Front Pharmacol2022;13:837503 PMCID:PMC8902254

[68] Sapio L,Spina A,Naviglio S.AdipoRon and pancreatic ductal adenocarcinoma: a future perspective in overcoming chemotherapy-induced resistance?.Cancer Drug Resist2022;5:625-36 PMCID:PMC9511794